Your browser doesn't support javascript.
loading
Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist.
Athanasoulia-Kaspar, Anastasia P; Popp, Kathrin H; Stalla, Gunter Karl.
Afiliação
  • Athanasoulia-Kaspar AP; Max Planck Institute of PsychiatryDepartment of Internal Medicine, Endocrinology and Clinical Chemistry, Munich, Germany athanasoulia_kaspar@psych.mpg.de stalla@psych.mpg.de.
  • Popp KH; Max Planck Institute of PsychiatryDepartment of Internal Medicine, Endocrinology and Clinical Chemistry, Munich, Germany.
  • Stalla GK; Max Planck Institute of PsychiatryDepartment of Internal Medicine, Endocrinology and Clinical Chemistry, Munich, Germany athanasoulia_kaspar@psych.mpg.de stalla@psych.mpg.de.
Endocr Connect ; 7(2): R88-R94, 2018 Feb.
Article em En | MEDLINE | ID: mdl-29378769
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Endocr Connect Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Endocr Connect Ano de publicação: 2018 Tipo de documento: Article